BioArctic revenue and financials
kr 302.20Change from previous close: +0.33%Absolute change: +kr 1.00
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,431 | -316 | 310 | -31.6 | — |
| Depreciation and amortization | 12.8 | 10.7 | 7.4 | 14.2 | — |
| Capital expenditure | -10.2 | -26.6 | -7.4 | -12.7 | — |
| Investing cash flow | -895 | 206 | -507 | -12.8 | — |
| Financing cash flow | 26.9 | 5.7 | 14.1 | -2.8 | — |
| Effect of exchange rates | -35.8 | 6.4 | -10.1 | 4.2 | — |
| Net change in cash | 563 | -105 | -184 | -47.2 | — |
| Free cash flow | 1,421 | -343 | 302 | -44.4 | — |